Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Intensity Inpatient MDMA-Assisted Psychotherapy for Treatment-Refractory Posttraumatic Stress Disorder: An Open-Label Pilot Study

NCT06954025 is registered in ClinicalTrials.gov with ARQ National Psychotrauma Centre as lead sponsor.

NCT NCT06954025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06954025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Intensity Inpatient MDMA-Assisted Psychotherapy for Treatment-Refractory Posttraumatic Stress Disorder: An Open-Label Pilot Study
Lead sponsor
ARQ National Psychotrauma Centre
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
May 16, 2025
Completion date
January 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

posttraumatic stress disorder (ptsd)